Skip to content

Impact of a Global Warming Strategy of the Patient on the Prevalence of Hypothermia in the Recovering Room

Impact of a Global Warming Strategy, From the Patient Arrival in the Operating Room to His Discharge From the Recovering Room, Versus a Recommended Management of Intraoperative Warming on the Prevalence of Hypothermia in the Recovering Room

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06551558
Acronym
REGLO
Enrollment
174
Registered
2024-08-13
Start date
2024-11-08
Completion date
2026-11-01
Last updated
2026-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothermia; Anesthesia, Perioperative/Postoperative Complications

Brief summary

50% of patients are hypothermic when they arrive in the recovery room. This hypothermia is potentially at risk for the patient (increases bleeding, risk of infection, risk of cardiac involvement, morbid mortality) and 33,2% steel hypothermic when they discharge from the recovering room. The anesthesia team must prevent these risks through prevention and treatment measures. Currently the majority of patient warming is done only in the operating room, we want to measure the impact of the extension of this warming before and after the surgery on the patient's temperature and on side effects related to hypothermia.

Detailed description

Hypothermia is defined as a core temperature below 36°C. It is classified by severity stage. A temperature below 36°C is mild hypothermia, below 35°C moderate hypothermia and below 34°C severe hypothermia. The impact of hypothermia on the body is related to decreased metabolic and immune activities. The vasoconstriction induced by hypothermia implies a decrease in vascularization of the organs that can cause tissue damage. These effects explain the role of hypothermia in the pathophysiology of certain perioperative and postoperative complications in the longer term. Intraoperative hypothermia is responsible for the increase of: * 4 times the risk of Surgical Site Infection, * twice the risk of cardiovascular morbidity, associated with increased mortality, * 33% of transfusion need, * 1.5 times the need for continued mechanical ventilation, * 3 times the duration of recovering room, * twice the hospital stay. This is why hypothermia is responsible for excess perioperative mortality. According to a 2019 study (Alfonsi P, Bekka S, Aegerter P, SFAR Research Network investigators. Prevalence of hypothermia on admission to recovery room remains high despite a large use of forced-air warming devices: Findings of a non-randomized observational multicenter and pragmatic study on perioperative hypothermia prevalence in France), the prevalence of hypothermia increases from 16.2% of patients before anesthetic induction to 53.5% of patients admitted to the Recovering room. At the end of Recovering room, 33.2% of patients were hypothermic. Among these patients, 15.2% became hypothermic during the recovering room stay. The risk factors for perioperative hypothermia are multiple: Patient-related factors: low body mass index; undernutrition; ASA score \> 1; pre-existing conditions altering thermoregulation (ex: diabetes with polyneuropathy, hypothyroidism, consumption of sedative or psychoactive drugs); pre-existing hypothermia at surgery. Factors related to anesthesia techniques: duration of anesthesia \> 2 hours; combined general and neuro-axial anesthesia; administration of large volumes of intravenous solutes or transfusion of non-rewarmed globular units. Factors related to surgery: type, extent and duration of surgery witch use of large amounts of unheated irrigation fluid.

Interventions

OTHERglobal warming

A systematic pre- and post-operative warming associated with the optimization of per-operative warming.

OTHERper operative warming

per-operative warming only thanks to the "Optimized" Forced air blanket with a prewarming of 10 minutes performed in the operating room.

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient undergoing laparoscopic visceral surgery under general anesthesia with transition to recovering room

Exclusion criteria

* Patient undergoing urgent surgery. * Presence of pre-existing infection (temperature higher than 38°C when receiving the patient in the hospital ward. * Patient with predetermined length of stay in recovering room.

Design outcomes

Primary

MeasureTime frameDescription
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the prevalence of hypothermia at the exit of Interventional for patients who underwent laparoscopic visceral surgery.1 dayProportion of patients with hypothermia after discharge of recovering room. Hypothermia is defined as a body temperature \< 36°C.

Secondary

MeasureTime frameDescription
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average total mechanical ventilation time1 dayit is the time between intubation and extubation, expressed in minutes.
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the average thermal comfort of preoperative patients, on arrival in the pre- anesthesia room1 dayevaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment)
Compare between the experimental group of global warming (RéGlo) and the control group of per- operative warming, the average thermal comfort of preoperative patients, on arrival in the recovering room1 dayevery 15minutes until discharge, evaluated by the Likert scale, ranging from 0 for discomfort too cold with strong chills to 4 for discomfort too hot with sweat with optimal comfort to 2 (self-assessment).
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, the proportion of patients in intraoperative hypothermia1 daynumber of patient with body temperature under 36°C between arrival in pre-operative room and discharge of operating room
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 36°C (mild hypothermia)1 dayexpressed in minutes.
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 35°C (moderate hypothermia)1 dayexpressed in minutes.
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average time spent below 34°C (severe hypothermia)1 dayexpressed in minutes.
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The lowest average temperature reached in °C over the entire management1 daythe lowest temperture between arrival in the pre-anaesthesia room and exit from recovering room
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The proportion of hypothermic patients arriving in recovering room1 daynumber of patient with a temperature below 36°C
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, The average duration of oxygen therapy1 daycalculated from the introduction of oxygen therapy until its withdrawal in post extubation, regardless of the time of implementation or cessation before resumption of treatment (failure to withdraw oxygen therapy will not be considered), expressed in minutes.
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of Nausea or Vomiting Postoperative1 daynumber of patient with Nausea or Vomiting in recovering room evaluated every 15 minutes until discharge
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of chills1 daynumber of chills during post-operative monitoring by a Likert scale
Compare between the experimental group of global warming (RéGlo) and the control group of per-operative warming, Post-intervention complications in recovering room, the average number of stirring phase presence1 daynumber of stirring phase evaluated every 15 minutes until discharge
The average amount of blood loss per operation1 dayblood loss measured from the time of entry into the operating theatre to the exit from the operating theatre expressed in millilitres.
The average of immediate post-operative blood loss1 dayblood loss measured in recovering room expressed in millilitres
The general average of the thermal variation1 daythe difference between the patient's lowest and highest temperature between their arrival in the pre-anaesthesia room and their exit from recovering room, expressed in degrees Celsius
The average of thermal variation in pre operative1 daythe difference between the lowest and highest temperature of the patient between the arrival in the waiting room of the operating room and the arrival in the operating room, expressed in degrees Celsius
The average thermal variation in per operative1 daythe difference between the lowest and highest temperature of the patient between the arrival and exit of the operating room, expressed in degrees Celsius
the average thermal variation in post operative1 daythe difference between the lowest and highest temperature of the patient between arrival in and validation exit criteria of recovering room,expressed in degrees Celsius
The average length of stay in recovering room1 daydifference between the time of arrival in recovering room and the time of obtaining the exit criteria , expressed in minutes.

Countries

France

Contacts

CONTACTMarion Said
marion.said@chu-poitiers.fr0549444444
PRINCIPAL_INVESTIGATORMatthieu Boisson, Pu-Ph

Poitiers University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 27, 2026